Syndax Pharmaceuticals Stock Quote SNDX - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

19.27

Bid

15.01

Ask

24.00

Volume

844,553

19.155 Day's Range 19.785

11.215 52 Week Range 25.34

Market Cap

1.635B

Previous Close

19.29

Open

19.45

Last Trade

20.2

Last Trade Time

Financial Volume

$ 16,279,252

VWAP

19.2756

Average Volume (3m)

1,061,712

Shares Outstanding

84,965,486

Dividend Yield

PE Ratio

-7.81

Earnings Per Share (EPS)

-2.46

Revenue

Net Profit

-209.36M

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and ... Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.syndax.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Syndax Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SNDX. The last closing price for Syndax Pharmaceuticals was $19.29. Over the last year, Syndax Pharmaceuticals shares have traded in a share price range of $ 11.215 to $ 25.34.

Syndax Pharmaceuticals currently has 84,965,486 shares outstanding. The market capitalization of Syndax Pharmaceuticals is $1.63 billion. Syndax Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.81.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.92	-4.55671124319	20.19	21.11	19.155	1181907	19.71041204	CS
4	-3.12	-13.934792318	22.39	23.215	19.155	943370	20.9122838	CS
12	-4.49	-18.8973063973	23.76	25.16	19.155	1061712	21.99845529	CS
26	2.76	16.7171411266	16.51	25.34	15.21	1293571	21.11122432	CS
52	-0.72	-3.60180090045	19.99	25.34	11.215	1298313	18.55034565	CS
156	0.77	4.16216216216	18.5	29.86	11.215	871047	19.50143887	CS
260	11.52	148.64516129	7.75	29.86	5.35	709124	18.9475029	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVOSNovo Integrated Sciences Inc	$ 1.05 (132.82%)	310.28M
BNAIBrand Engagement Network Inc	$ 5.4799 (112.40%)	67.99M
PRTGPortage Biotech Inc	$ 0.51 (98.44%)	4.26M
PLTNUPlutoniam Acquisition Corporation	$ 12.06 (81.63%)	1.81k
PEGRUProject Energy Reimagined Acquisition Corporation	$ 11.43 (36.89%)	1.19k
WBUYWeBuy Global Ltd	$ 0.241 (-61.75%)	22.54M
SMFLSmart for Life Inc	$ 3.40 (-43.05%)	2.77M
TOIIWOncology Institute Inc	$ 0.016 (-40.74%)	5.5k
SIFYSify Technologies Limited	$ 1.105 (-34.23%)	3.69M
LOTLotus Technology Inc	$ 9.78 (-25.00%)	832.27k
NVOSNovo Integrated Sciences Inc	$ 1.05 (132.82%)	310.28M
GWAVGreenwave Technology Solutions Inc	$ 0.0387 (-7.86%)	305.13M
FFIEFaraday Future Intelligent Electric Inc	$ 0.584899 (3.47%)	223.84M
SQQQProShares UltraPro Short QQQ	$ 10.02 (0.00%)	161.89M
CRKNCrown Electrokinetics Corporation	$ 0.0998 (-12.07%)	155.13M